# US 2003/0225247 A1 · Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0225247 A1
- Document ID: US20030225247A1
- Status: Published application
- Kind: A1
- Application number: 10/096,075
- Filed: 2002-03-12
- Published: 2003-12-04
- Earliest claimed: 2002-03-12
- Assignees: Enzo Life Sciences, Inc. C/O Enzo Biochem, Inc.
- Inventors: Jannis G. Stavrianopoulos; Elazar Rabbani
- Web page: https://patentgrep.com/patent/US20030225247A1

## CPC

- C07H 21/00: Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C09B 23/02: the polymethine chain containing an odd number of >CH- {or >C[alkyl]-} groups
- C09B 47/00: Porphines; Azaporphines {(non-dyeing compounds C07D487/22)}
- C09B 57/00: Other synthetic dyes of known constitution
- Y10S 436/80: Fluorescent dyes, e.g. rhodamine
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

This invention provides for labeling reagents, labeled targets and processes for preparing labeling reagents. The labeling reagents can take the form of cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes. These labeling reagents are useful for labeling probes or targets, including nucleic acids and proteins. These reagents can be usefully applied to protein and nucleic acid probe based assays. They are also applicable to real-time detection processes.

## Claims

### Claim 1

A labeling reagent for labeling a target, said labeling reagent comprising a marker moiety M and a reactive group R
M-R
wherein said marker moiety M and said reactive group R are covalently linked together, said M comprising at least one moiety that comprises a ligand, a dye, or both a ligand and a dye; and said reactive group R being capable of forming a carbon-carbon linkage with said target.

### Claim 2 (depends on 1)

The labeling reagent of claim 1, wherein said target comprises a protein, a peptide, a nucleic acid, a nucleotide or a nucleotide analog, a receptor, a natural or synthetic drug, a synthetic oligomer, a synthetic polymer, a hormone, a lymphokine, a cytokine, a toxin, a ligand, an antigen, a hapten, an antibody, a carbohydrate, a sugar or an oligo- or polysaccharide.

### Claim 3 (depends on 2)

The labeling reagent of claim 2, wherein said nucleic acid or nucleotide or nucleotide analog is modified.

### Claim 4 (depends on 1)

The labeling reagent of claim 1, wherein said ligand comprises biotin, iminobiotin, digoxygenin or fluorescein.

### Claim 5 (depends on 1)

The labeling reagent of claim 1, wherein said dye comprises a fluorescent dye.

### Claim 6 (depends on 5)

The labeling reagent of claim 5, wherein said fluorescent dye comprises a xanthene dye, a cyanine dye, a coumarin dye, a porphyrin dye or a composite dye.

### Claim 7 (depends on 6)

The labeling reagent of claim 6, wherein said xanthene dye comprises fluorescein, rhodamine or rhodol, or derivatives thereof.

### Claim 8 (depends on 1)

The labeling reagent of claim 1, further comprising a linker arm between said marker moiety M and said reactive group R.

### Claim 9 (depends on 8)

The labeling reagent of claim 8, wherein said linker arm is flexible, semi-rigid or rigid.

### Claim 10 (depends on 8)

The labeling reagent of claim 8, wherein said linker arm has a backbone comprising one or more carbon atoms.

### Claim 11 (depends on 8)

The labeling reagent of claim 8, wherein said linker arm has a backbone comprising at least one non-carbon atom.

### Claim 12 (depends on 11)

The labeling reagent of claim 11, wherein said non-carbon atom comprises sulfur, oxygen or nitrogen.

### Claim 13 (depends on 10)

The labeling reagent of claim 10, wherein said backbone comprises one or more peptide bonds.

### Claim 14 (depends on 1)

The labeling reagent of claim 1, wherein said reactive group R comprises an alkene group, an alkyne group, a halogenated compound or a metallo-organic compound.

### Claim 15 (depends on 14)

The labeling reagent of claim 14, wherein said metallo-organic compound comprises mercury, zinc, copper or platinum.

### Claim 16 (depends on 14)

The labeling reagent of claim 14, wherein said metallo-organic compound comprises an aromatic group, an aromatic heterocyclic group, an alkene group or an alkyne group.

### Claim 17

A process for labeling a target, said process comprising the steps of:
(a) providing:
(i) said target;
(ii) a labeling reagent comprising a marker moiety M and a reactive group R
M-R
wherein said marker moiety M and said reactive group R are covalently linked together, said M comprising at least one moiety that comprises a ligand, a dye, or both a ligand and a dye; and said reactive group R being capable of forming a carbon-carbon linkage with said target; and
(b) reacting said target (i) and said labeling reagent (ii) under conditions such that a carbon-carbon linkage forms between said target (i) and said labeling reagent (ii), thereby labeling said target (i) with said marker moiety M.

### Claim 18 (depends on 17)

The process of claim 17, wherein in said providing step, the target comprises a protein, a peptide, a nucleic acid, a nucleotide or a nucleotide analog, a receptor, a natural or synthetic drug, a synthetic oligomer, a synthetic polymer, a hormone, a lymphokine, a cytokine, a toxin, a ligand, an antigen, a hapten, an antibody, a carbohydrate, a sugar or an oligo- or polysaccharide.

### Claim 19 (depends on 17)

The process of claim 17, wherein in said providing step, the ligand comprises biotin, iminobiotin, digoxygenin or fluorescein, and the dye comprises a fluorescent dye.

### Claim 20 (depends on 19)

The process of claim 19, wherein said fluorescent dye comprises a xanthene dye, a cyanine dye, a coumarin dye, a porphyrin dye or a composite dye.

### Claim 21 (depends on 17)

The process of claim 17, wherein said providing or reacting step, the reactive group R comprises an alkene group, an alkyne group, a halogenated compound or a metallo-organic compound.

### Claim 22 (depends on 17)

The process of claim 17, wherein in said providing step, the target has been modified.

### Claim 23 (depends on 22)

The process of claim 22, wherein said modified target comprises an alkene group, an alkyne group, a halogenated compound or a metallo-organic compound.

### Claim 24

A labeled target, said target having been labeled by a process comprising the steps of:
(a) providing:
(i) said target;
(ii) a labeling reagent comprising a marker moiety M and a reactive group R
M-R
wherein said marker moiety M and said reactive group R are covalently linked together, said M comprising at least one moiety that comprises a ligand, a dye, or both a ligand and a dye; and said reactive group R being capable of forming a carbon-carbon linkage with said target;
(b) reacting said target (i) and said labeling reagent (ii) under conditions such that a carbon-carbon linkage forms between said target (i) and said labeling reagent (ii), thereby labeling said target (i) with said marker moiety M.

### Claim 25 (depends on 24)

The process of claim 24, wherein in said providing step, the target comprises a protein, a peptide, a nucleic acid, a nucleotide or a nucleotide analog, a receptor, a natural or synthetic drug, a synthetic oligomer, a synthetic polymer, a hormone, a lymphokine, a cytokine, a toxin, a ligand, an antigen, a hapten, an antibody, a carbohydrate, a sugar or an oligo- or polysaccharide.

### Claim 26 (depends on 24)

The process of claim 24, wherein in said providing step, the ligand comprises biotin, iminobiotin, digoxygenin or fluorescein, and the dye comprises a fluorescent dye.

### Claim 27 (depends on 26)

The process of claim 26, wherein said fluorescent dye comprises a xanthene dye, a cyanine dye, a coumarin dye, a porphyrin dye or a composite dye.

### Claim 28 (depends on 24)

The process of claim 24, wherein said providing or reacting step, the reactive group R comprises an alkene group, an alkyne group, a halogenated compound or a metallo-organic compound.

### Claim 29 (depends on 24)

The process of claim 24, wherein in said providing step, the target has been modified.

### Claim 30 (depends on 29)

The process of claim 29, wherein said modified target comprises an alkene group, an alkyne group, a halogenated compound or a metallo-organic compound.

### Claim 31

A process for preparing a cyanine dye labeling reagent, said process comprising the steps of:
(a) providing:
(i) a first intermediate compound comprising:
22
wherein X1 comprises carbon, oxygen, nitrogen or sulfur; and
(ii) a second intermediate compound comprising:
23
wherein X1 comprises carbon, oxygen, nitrogen or sulfur;
wherein at least one of R1 through R10 comprises a reactive group capable of forming a carbon-carbon linkage with a target, and
(ii) linking reagents suitable for linking said first intermediate compound and said second intermediate compound;
(b) forming a reaction mixture comprising said first intermediate compound (i), said second intermediate compound (ii), and said linking reagents under conditions to link (i) and (ii) to form
24
wherein at least one of R1 through R10 comprises a reactive group capable of forming a carbon-carbon linkage with a target, and wherein n is an integer of 1, 2 or 3, and wherein X1 and X2 independently comprise carbon, oxygen, nitrogen or sulfur.

### Claim 32 (depends on 31)

The process of claim 31, wherein said providing step, the reactive group comprises an alkene group, an alkyne group, a halogenated compound or a metallo-organic compound.

### Claim 33 (depends on 31)

The process of claim 31, wherein R1 through R10 independently comprise hydrogen, C1-C6 alkyl, a C0-C4 alkyl group having a hydrophilic substituent comprising sulfonate, carboxylate, hydroxyl, substituted amines and quaternary amines, aliphatic, alkenes, alkynes, charged or polar groups, or combinations of any of the foregoing.

### Claim 34

A labeling reagent comprising an aphenylic analog of a rhodamine dye, said analog comprising at least one reactive group for attaching said labeling reagent to a target, said at least one reactive group being attached directly to said analog or indirectly through a linker arm.

### Claim 35 (depends on 34)

The labeling reagent of claim 34, said reagent having the structure
25
wherein R is a reactive group for attaching said labeling reagent to a target, and wherein R is attached directly or indirectly through an aphenylic linker arm.

### Claim 36 (depends on 34)

The labeling reagent of claim 34, said reagent having the structure
26
wherein R is a reactive group for attaching said labeling reagent to a target, and
wherein R is attached directly or indirectly through an aphenylic linker arm.

### Claim 37 (depends on 34, 35, 36)

The labeling reagent of claim 34, 35 or 36, wherein said reactive group comprises sulfhydryl, hydroxyl, amine, isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, maleimide, aziridine, sulfonylhalide, acid halide, hydroxysuccinimide ester, hydroxysulfosuccinimide ester, imidoester, hydrazine, azidonitrophenyl, azide, 3-(2-pyridyl dithio)-proprionamide, glyoxal or aldehyde.

### Claim 38 (depends on 34, 35, 36)

The labeling reagent of claim 34, 35 or 36, wherein said reactive group is capable of forming a carbon-carbon linkage with a target.

### Claim 39 (depends on 38)

The labeling reagent of claim 38, wherein said reactive group comprises an alkene group, an alkyne group, a halogenated compound or a metallo-organic compound.

### Claim 40 (depends on 39)

The labeling reagent of claim 39, wherein said metallo-organic compound comprises mercury, zinc, copper or platinum.

### Claim 41 (depends on 39)

The labeling reagent of claim 39, wherein said metallo-organic compound comprises an alkene group or an alkyne group.

### Claim 42 (depends on 34)

The labeling reagent of claim 34, wherein said aphenylic linker arm has a backbone comprising one or more carbon atoms.

### Claim 43 (depends on 34)

The labeling reagent of claim 34, wherein said aphenylic linker arm has a backbone comprising at least one non-carbon atom.

### Claim 44

A labeled nucleotide comprising an aphenylic analog of a rhodamine dye, wherein said dye is attached directly to said nucleotide or indirectly through a linker.

### Claim 45 (depends on 44)

The labeled nucleotide of claim 44, said labeled nucleotide having the structure:
27
wherein Nt comprises a nucleotide.

### Claim 46 (depends on 44)

The labeled nucleotide of claim 44, said labeled nucleotide having the structure:
28
wherein Nt comprises a nucleotide.

### Claim 47 (depends on 44, 45, 46)

The labeled nucleotide of claims 44, 45 or 46, wherein said nucleotide comprises a mono-phosphate, a di-phosphate or a tri-phosphate.

### Claim 48 (depends on 44, 45, 46)

The labeled nucleotide of claims 44, 45 or 46, wherein said linker arm has a backbone comprising one or more carbon atoms.

### Claim 49 (depends on 44, 45, 46)

The labeled nucleotide of claims 44, 45 or 46, wherein said linker arm has a backbone comprising at least one non-carbon atom.

### Claim 50 (depends on 44, 45, 46)

The labeled nucleotide of claims 44, 45 or 46, wherein said linker arm comprises two or more consecutive peptide bonds.

### Claim 51

A labeled target comprising
T-L-M
wherein T is a target, M is a marker moiety and L is a chemical group covalently linking said M to T, said chemical group L comprising a backbone that comprises at least one rigid group that comprises one or more of:
29
(d) multimers of (a), (b) or (c),
and (e) any combinations of (a), (b), (c) and (d).

### Claim 52 (depends on 51)

The labeled target of claim 51, wherein said target T comprises a protein, a peptide, a nucleic acid, a nucleotide or a nucleotide analog, a receptor, a natural or synthetic drug, a synthetic oligomer, a synthetic polymer, a hormone, a lymphokine, a cytokine, a toxin, a ligand, an antigen, a hapten, an antibody, a carbohydrate, a sugar or an oligo- or polysaccharide.

### Claim 53 (depends on 52)

The labeled target of claim 52, wherein said nucleic acid or nucleotide or nucleotide analog is modified.

### Claim 54 (depends on 52)

The labeled target of claim 52, wherein said ligand comprises biotin, iminobiotin, digoxygenin or fluorescein.

### Claim 55 (depends on 51)

The labeled target of claim 51, wherein said marker moiety M comprises a ligand that comprises biotin, iminobiotin, digoxygenin or fluorescein.

### Claim 56 (depends on 51)

The labeled target of claim 51, wherein said marker moiety M comprises a fluorescent dye.

### Claim 57 (depends on 56)

The labeled target of claim 56, wherein said fluorescent dye comprises a xanthene dye, a cyanine dye, a coumarin dye, a porphyrin dye or a composite dye.

### Claim 58 (depends on 57)

The labeled target of claim 57, wherein said xanthene dye comprises fluorescein, rhodamine or rhodol, or derivatives thereof.

### Claim 59 (depends on 51)

The labeled target of claim 51, wherein said backbone comprises one or more carbon atoms.

### Claim 60 (depends on 51)

The labeled target of claim 51, wherein said backbone comprises at least one non-carbon atom.

### Claim 61 (depends on 60)

The labeled target of claim 60, wherein said non-carbon atom comprises sulfur, oxygen or nitrogen.

### Claim 62 (depends on 51)

The labeled target of claim 51, wherein said chemical group L further comprises at least one additional moiety comprising peptide bonds, amino acids, aliphatic chains from C1 through C20, alkene groups, alkyne groups, saturated or unsaturated or partially saturated rings, heterocyclic rings and sugars.

### Claim 63 (depends on 51)

The labeled target of claim 51, wherein said structure (a) comprises two alkene groups in cis conformation to each other.

### Claim 64 (depends on 51)

The labeled target of claim 51, wherein said structure (a) comprises two alkene groups in trans conformation to each other.

### Claim 65 (depends on 51)

The labeling reagent of claim 51, wherein one or more hydrogens are substituted by a chemical moiety.

### Claim 66

A labeling reagent comprising
R-L-M
wherein R is a reactive group, M is a marker moiety and L is a chemical group covalently linking said M to R, said chemical group L comprising a backbone that comprises at least one rigid group that comprises one or more of:
30
(d) multimers of (a), (b) or (c),
and (e) any combinations of (a), (b), (c) and (d).

### Claim 67 (depends on 66)

The labeling reagent of claim 66, wherein said reactive group R comprises sulfhydryl, hydroxyl, amine, isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, maleimide, aziridine, sulfonylhalide, acid halide, hydroxysuccinimide ester, hydroxysulfosuccinimide ester, imidoester, hydrazine, azidonitrophenyl, azide, 3-(2-pyridyl dithio)-proprionamide, glyoxal or aldehyde.

### Claim 68 (depends on 67)

The labeling reagent of claim 67, wherein as a reactive group R is capable of forming a carbon-carbon linkage with a target.

### Claim 69 (depends on 68)

The labeling reagent of claim 68, wherein said reactive group R comprises an alkene group, an alkyne group, a halogenated compound or a metallo-organic compound.

### Claim 70 (depends on 69)

The labeling reagent of claim 69, wherein said metallo-organic compound comprises mercury, zinc, copper or platinum.

### Claim 71 (depends on 69)

The labeling reagent of claim 69, wherein said metallo-organic compound comprises an aromatic group, an aromatic heterocyclic group, an alkene group or an alkyne group.

### Claim 72 (depends on 66)

The labeling reagent of claim 66, wherein said marker moiety M comprises a ligand that comprises biotin, iminobiotin, digoxygenin or fluorescein.

### Claim 73 (depends on 66)

The labeling reagent of claim 66, wherein said marker moiety M comprises a fluorescent dye.

### Claim 74 (depends on 73)

The labeling reagent of claim 73, wherein said fluorescent dye comprises a xanthene dye, a cyanine dye, a coumarin dye, a porphyrin dye or a composite dye.

### Claim 75 (depends on 74)

The labeling reagent of claim 74, wherein said xanthene dye comprises fluorescein, rhodamine or rhodol, or derivatives thereof.

### Claim 76 (depends on 66)

The labeling reagent of claim 66, wherein said backbone comprises one or more carbon atoms.

### Claim 77 (depends on 66)

The labeling reagent of claim 66, wherein said backbone comprises at least one non-carbon atom.

### Claim 78 (depends on 77)

The labeling reagent of claim 77, wherein said non-carbon atom comprises sulfur, oxygen or nitrogen.

### Claim 79 (depends on 77)

The labeling reagent of claim 77, wherein said chemical group L further comprises at least one additional moiety comprising peptide bonds, amino acids, aliphatic chains from C1 through C20, alkene groups, alkyne groups, saturated or unsaturated or partially saturated rings, heterocyclic rings and sugars.

### Claim 80 (depends on 66)

The labeling reagent of claim 66, wherein said structure (a) comprises two alkene groups in cis conformation to each other.

### Claim 81 (depends on 66)

The labeling reagent of claim 66, wherein said structure (a) comprises two alkene groups in trans conformation to each other.

### Claim 82 (depends on 66)

The labeling reagent of claim 66, wherein one or more hydrogens are substituted by a chemical moiety.

### Claim 83

A labeled target comprising
T-L-M
wherein T is a target, M is a marker moiety and L is a chemical group covalently linking said M to T, said chemical group L comprising a backbone that comprises at least two consecutive polar rigid units.

### Claim 84 (depends on 83)

The labeled target of claim 83, wherein said target T comprises a protein, a peptide, a nucleic acid, a nucleotide or a nucleotide analog, a receptor, a natural or synthetic drug, a synthetic oligomer, a synthetic polymer, a hormone, a lymphokine, a cytokine, a toxin, a ligand, an antigen, a hapten, an antibody, a carbohydrate, a sugar or an oligo- or polysaccharide.

### Claim 85 (depends on 84)

The labeled target of claim 84, wherein said nucleic acid or nucleotide or nucleotide analog is modified.

### Claim 86 (depends on 84)

The labeled target of claim 84, wherein said ligand comprises biotin, iminobiotin, digoxygenin or fluorescein.

### Claim 87 (depends on 83)

The labeled target of claim 83, wherein said marker moiety M comprises a ligand that comprises biotin, iminobiotin, digoxygenin or fluorescein.

### Claim 88 (depends on 83)

The labeled target of claim 83, wherein said marker moiety M comprises a fluorescent dye.

### Claim 89 (depends on 88)

The labeled target of claim 88, wherein said fluorescent dye comprises a xanthene dye, a cyanine dye, a coumarin dye, a porphyrin dye or a composite dye.

### Claim 90 (depends on 89)

The labeled target of claim 89, wherein said xanthene dye comprises fluorescein, rhodamine or rhodol, or derivatives thereof.

### Claim 91 (depends on 83)

The labeled target of claim 83, wherein at least one of said two consecutive rigid polar units of said backbone is heteroatomic.

### Claim 92 (depends on 91)

The labeled target of claim 91, wherein said heteroatomic backbone comprises a carbon atom that is bonded to a N, S, O, P or halogen atom.

### Claim 93 (depends on 91)

The labeled target of claim 91, wherein said heteroatom comprises an —OH, —SH, —SO3, —PO4, —COOH or —NH2 groups.

### Claim 94 (depends on 91)

The labeled target of claim 91, wherein at least one of said two consecutive rigid polar units comprises a peptide bond.

### Claim 95 (depends on 91)

The labeled target of claim 91, wherein at least one of said two consecutive polar units comprises a ring structure.

### Claim 96 (depends on 95)

The labeled target of claim 95, wherein said ring structure further comprises polar or charged functional groups attached to said ring.

### Claim 97 (depends on 96)

The labeled target of claim 96, wherein said polar or charged functional groups comprise halide, —OH, —SH, —SO3, —PO4, —COOH or —NH2 groups.

### Claim 98 (depends on 95)

The labeled target of claim 95, wherein said ring structure comprises a sugar.

### Claim 99 (depends on 95)

The labeled target of claim 95, wherein said ring structure comprises a substituted heterocyclic aromatic compound.

### Claim 100 (depends on 83)

The labeled target of claim 83, wherein said backbone comprises one or more carbon atoms.

### Claim 101 (depends on 83)

The labeled target of claim 83, wherein said backbone comprises at least one non-carbon atom.

### Claim 102 (depends on 101)

The labeled target of claim 101, wherein said non-carbon atom comprises sulfur, oxygen or nitrogen.

### Claim 103 (depends on 83)

The labeled target of claim 83, wherein said chemical group L further comprises at least one additional moiety comprising peptide bonds, amino acids, aliphatic chains from C1 through C20, alkene groups, alkyne groups, saturated or unsaturated or partially saturated rings, heterocyclic rings and sugars.

### Claim 104

A labeling reagent comprising
R-L-M
wherein R is a reactive group, M is a marker moiety and L is a chemical group covalently linking said M to R, said chemical group L comprising a backbone that comprises at least two consecutive polar rigid units.

### Claim 105 (depends on 104)

The labeling reagent of claim 104, wherein said reactive group R comprises sulfhydryl, hydroxyl, amine, isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, maleimide, aziridine, sulfonylhalide, acid halide, hydroxysuccinimide ester, hydroxysulfosuccinimide ester, imidoester, hydrazine, azidonitrophenyl, azide, 3-(2-pyridyl dithio)-proprionamide, glyoxal or aldehyde.

### Claim 106 (depends on 104)

The labeling reagent of claim 104, wherein as a reactive group R is capable of forming a carbon-carbon linkage with a target.

### Claim 107 (depends on 104)

The labeling reagent of claim 104, wherein said reactive group R comprises an alkene group, an alkyne group, a halogenated compound or a metallo-organic compound.

### Claim 108 (depends on 107)

The labeling reagent of claim 107, wherein said metallo-organic compound comprises mercury, zinc, copper or platinum.

### Claim 109 (depends on 107)

The labeling reagent of claim 107, wherein said metallo-organic compound comprises an aromatic group, an aromatic heterocyclic group, an alkene group or an alkyne group.

### Claim 110 (depends on 104)

The labeling reagent of claim 104, wherein said marker moiety M comprises a ligand that comprises biotin, iminobiotin, digoxygenin or fluorescein.

### Claim 111 (depends on 104)

The labeling reagent of claim 104, wherein said marker moiety M comprises a fluorescent dye.

### Claim 112 (depends on 111)

The labeling reagent of claim 111, wherein said fluorescent dye comprises a xanthene dye, a cyanine dye, a coumarin dye, a porphyrin dye or a composite dye.

### Claim 113 (depends on 112)

The labeling reagent of claim 112, wherein said xanthene dye comprises fluorescein, rhodamine or rhodol, or derivatives thereof.

### Claim 114 (depends on 104)

The labeled target of claim 104, wherein at least one of said two consecutive rigid polar units is heteroatomic.

### Claim 115 (depends on 114)

The labeled target of claim 114, wherein said heteroatomic rigid polar units comprises a carbon atom that is bonded to a N, S, O, P or halogen atom.

### Claim 116 (depends on 114)

The labeled target of claim 114, wherein said heteroatom comprises an —OH, —SH, —SO3, —PO4, —COOH or —NH2 groups.

### Claim 117 (depends on 104)

The labeled target of claim 104, wherein at least one of said two consecutive rigid polar units comprises a peptide bond.

### Claim 118 (depends on 104)

The labeled target of claim 104, wherein at least one of said two consecutive polar units comprises a ring structure.

### Claim 119 (depends on 118)

The labeled target of claim 118, wherein said ring structure further comprises polar or charged functional groups attached to said ring.

### Claim 120 (depends on 119)

The labeled target of claim 119, wherein said polar or charged functional groups comprise halide, —OH, —SH, —SO3, —PO4, —COOH or —NH2 groups.

### Claim 121 (depends on 118)

The labeled target of claim 118, wherein said ring structure comprises a sugar.

### Claim 122 (depends on 118)

The labeled target of claim 118, wherein said ring structure comprises a substituted heterocyclic aromatic compound.

### Claim 123 (depends on 104)

The labeling reagent of claim 104, wherein said backbone comprises one or more carbon atoms.

### Claim 124 (depends on 104)

The labeling reagent of claim 104, wherein said backbone comprises at least one non-carbon atom.

### Claim 125 (depends on 124)

The labeling reagent of claim 124, wherein said non-carbon atom comprises sulfur, oxygen or nitrogen.

### Claim 126 (depends on 104)

The labeling reagent of claim 104, wherein said chemical group L further comprises at least one additional moiety comprising peptide bonds, amino acids, aliphatic chains from C1 through C20, alkene groups, alkyne groups, saturated or unsaturated or partially saturated rings, heterocyclic rings and sugars.

### Claim 127

A labeled target comprising
T-L-M
wherein T is a target, M is a marker moiety and L is a chemical group covalently linking said M to T, said chemical group L comprising a backbone that comprises at least two consecutive peptide bonds.

### Claim 128 (depends on 242)

The labeled target of claim 242, wherein said target T comprises a protein, a peptide, a nucleic acid, a nucleotide or a nucleotide analog, a receptor, a natural or synthetic drug, a synthetic oligomer, a synthetic polymer, a hormone, a lymphokine, a cytokine, a toxin, a ligand, an antigen, a hapten, an antibody, a carbohydrate, a sugar or an oligo- or polysaccharide.

### Claim 129 (depends on 128)

The labeled target of claim 128, wherein said nucleic acid or nucleotide or nucleotide analog is modified.

### Claim 130 (depends on 128)

The labeled target of claim 128, wherein said ligand comprises biotin, iminobiotin, digoxygenin or fluorescein.

### Claim 131 (depends on 127)

The labeled target of claim 127, wherein said marker moiety M comprises a ligand that comprises biotin, iminobiotin, digoxygenin or fluorescein.

### Claim 132 (depends on 127)

The labeled target of claim 127, wherein said marker moiety M comprises a fluorescent dye.

### Claim 133 (depends on 132)

The labeled target of claim 132, wherein said fluorescent dye comprises a xanthene dye, a cyanine dye, a coumarin dye, a porphyrin dye or a composite dye.

### Claim 134 (depends on 133)

The labeled target of claim 133, wherein said xanthene dye comprises fluorescein, rhodamine or rhodol, or derivatives thereof.

### Claim 135 (depends on 127)

The labeled target of claim 127, wherein at least one of said two consecutive peptide bonds are separated by a single atom.

### Claim 136 (depends on 135)

The labeled target of claim 135, wherein said single atom comprises C, N, S, O or P.

### Claim 137 (depends on 127)

The labeled target of claim 127, wherein said backbone comprises one or more carbon atoms.

### Claim 138 (depends on 127)

The labeled target of claim 127, wherein said backbone comprises at least one non-carbon atom.

### Claim 139 (depends on 138)

The labeled target of claim 138, wherein said non-carbon atom comprises sulfur, oxygen or nitrogen.

### Claim 140 (depends on 127)

The labeled target of claim 127, wherein said chemical group L further comprises at least one additional moiety comprising peptide bonds, amino acids, aliphatic chains from C1 through C20, alkene groups, alkyne groups, saturated or unsaturated or partially saturated rings, heterocyclic rings and sugars.

### Claim 141 (depends on 127)

The labeled target of claim 127, wherein said chemical group L comprises a di-peptide or an oligo-peptide.

### Claim 142 (depends on 141)

The labeled target of claim 141, wherein said di-peptide or oligo-peptide comprises (glycine)2 or (glycine)4.

### Claim 143

A labeling reagent comprising
R-L-M
wherein R is a reactive group, M is a marker moiety and L is a chemical group covalently linking said M to R, said chemical group L comprising a backbone that comprises at least two consecutive peptide bonds.

### Claim 144 (depends on 143)

The labeling reagent of claim 143, wherein said reactive group R comprises sulfhydryl, hydroxyl, amine, isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, maleimide, aziridine, sulfonylhalide, acid halide, hydroxysuccinimide ester, hydroxysulfosuccinimide ester, imidoester, hydrazine, azidonitrophenyl, azide, 3-(2-pyridyl dithio)-proprionamide, glyoxal or aldehyde.

### Claim 145 (depends on 143)

The labeling reagent of claim 143, wherein as a reactive group R is capable of forming a carbon-carbon linkage with a target.

### Claim 146 (depends on 143)

The labeling reagent of claim 143, wherein said reactive group R comprises an alkene group, an alkyne group, a halogenated compound or a metallo-organic compound.

### Claim 147 (depends on 146)

The labeling reagent of claim 146, wherein said metallo-organic compound comprises mercury, zinc, copper or platinum.

### Claim 148 (depends on 146)

The labeling reagent of claim 146, wherein said metallo-organic compound comprises an aromatic group, an aromatic heterocyclic group, an alkene group or an alkyne group.

### Claim 149 (depends on 143)

The labeling reagent of claim 143, wherein said marker moiety M comprises a ligand that comprises biotin, iminobiotin, digoxygenin or fluorescein.

### Claim 150 (depends on 143)

The labeling reagent of claim 143, wherein said marker moiety M comprises a fluorescent dye.

### Claim 151 (depends on 150)

The labeling reagent of claim 150, wherein said fluorescent dye comprises a xanthene dye, a cyanine dye, a coumarin dye, a porphyrin dye or a composite dye.

### Claim 152 (depends on 151)

The labeling reagent of claim 151, wherein said xanthene dye comprises fluorescein, rhodamine or rhodol, or derivatives thereof.

### Claim 153 (depends on 143)

The labeled target of claim 143, wherein at least one of said two consecutive peptide bonds are separated by a single atom.

### Claim 154 (depends on 153)

The labeled target of claim 153, wherein said single atom comprises C, N, S, O or P.

### Claim 155 (depends on 143)

The labeled target of claim 143, wherein said backbone comprises one or more carbon atoms.

### Claim 156 (depends on 143)

The labeled target of claim 143, wherein said backbone comprises at least one non-carbon atom.

### Claim 157 (depends on 143)

The labeled target of claim 143, wherein said non-carbon atom comprises sulfur, oxygen or nitrogen.

### Claim 158 (depends on 143)

The labeled target of claim 143, wherein said chemical group L further comprises at least one additional moiety comprising peptide bonds, amino acids, aliphatic chains from C1 through C20, alkene groups, alkyne groups, saturated or unsaturated or partially saturated rings, heterocyclic rings and sugars.

### Claim 159 (depends on 143)

The labeled target of claim 143, wherein said chemical group L comprises a di-peptide or an oligo-peptide.

### Claim 160 (depends on 159)

The labeled target of claim 159, wherein said di-peptide or oligo-peptide comprises (glycine)2 or (glycine)4.

### Claim 161

A labeling reagent comprising a nonmetallic porphyrin, said reagent comprising:
31
wherein R0 is a reactive group and is attached directly or indirectly to said nonmetallic porphyrin, and R1 through R8 independently comprise hydrogen, aliphatic, unsaturated aliphatic, cyclic, heterocyclic, aromatic, heteroaromatic, charged or polar groups, or any combinations of the foregoing.

### Claim 162 (depends on 161)

The labeling reagent of claim 161, wherein said reactive group R0 is attached directly or indirectly to any one of the four non-pyrrole positions.

### Claim 163 (depends on 161)

The labeling reagent of claim 161, wherein said reactive group Ro comprises sulfhydryl, hydroxyl, amine, isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, maleimide, aziridine, sulfonylhalide, acid halide, hydroxysuccinimide ester, hydroxysulfosuccinimide ester, imidoester, hydrazine, azidonitrophenyl, azide, 3-(2-pyridyl dithio)-proprionamide, glyoxal or aldehyde.

### Claim 164 (depends on 161)

The labeling reagent of claim 161, wherein as a reactive group R0 is capable of forming a carbon-carbon linkage with a target.

### Claim 165 (depends on 161)

The labeling reagent of claim 161, wherein said reactive group R0 comprises an alkene group, an alkyne group or a halogenated compound.

### Claim 166 (depends on 161)

The labeling reagent of claim 161, wherein any of said R1 through R8 alkyl groups comprises methyl, ethyl or propyl.

### Claim 167 (depends on 161)

The labeling reagent of claim 161, wherein any of said R1 through R8 alkyl groups further comprises a polar or charged group.

### Claim 168 (depends on 161)

The labeling reagent of claim 161, wherein said reactive group R0 is attached indirectly to said nonmetallic porphyrin through a linker arm.

### Claim 169 (depends on 168)

The labeling reagent of claim 168, wherein said linker arm comprises at least two consecutive peptide bonds.

### Claim 170

A labeled target comprising a nonmetallic porphyrin, said reagent comprising:
32
wherein T is a target molecule attached directly or indirectly to said nonmetallic porphyrin and R1 through R8 independently comprise hydrogen, aliphatic, unsaturated aliphatic, cyclic, heterocyclic, aromatic, heteroaromatic, charged or polar groups, or any combinations of the foregoing.

### Claim 171 (depends on 170)

The labeled target of claim 170, wherein said reactive group R0 is attached directly or indirectly to any one of the four non-pyrrole positions.

### Claim 172 (depends on 170)

The labeled target of claim 170, wherein said target T comprises a protein, a peptide, a nucleic acid, a nucleotide or a nucleotide analog, a receptor, a natural or synthetic drug, a synthetic oligomer, a synthetic polymer, a hormone, a lymphokine, a cytokine, a toxin, a hapten, an antibody, a carbohydrate, a sugar or an oligo- or polysaccharide.

### Claim 173 (depends on 172)

The labeled target of claim 172, wherein said nucleic acid or nucleotide or nucleotide analog is modified.

### Claim 174 (depends on 170)

The labeling reagent of claim 170, wherein any of said R1 through R8 alkyl groups comprises methyl, ethyl or propyl.

### Claim 175 (depends on 170)

The labeling reagent of claim 170, wherein any of said R1 through R8 alkyl groups further comprises a polar or charged group.

### Claim 176 (depends on 170)

The labeling reagent of claim 170, wherein said target T is attached indirectly to said nonmetallic porphyrin through a linker arm.

### Claim 177 (depends on 176)

The labeling reagent of claim 176, wherein said linker arm comprises at least two consecutive peptide bonds.

### Claim 178

A process for determining the amount of a nucleic acid in a sample of interest, said process comprising the steps of:
(a) providing:
(i) said sample of interest;
(ii) a dye comprising a first phenanthridinium moiety linked to a second phenanthridinium moiety through a phenyl group in each of said first and second phenanthridinium moieties;
(iii) reagents for carrying out dye binding, hybridization, strand extension, or any combination thereof;
(b) forming a mixture of (i), (ii) and (iii) above, to produce a complex comprising said dye (ii) and any nucleic acid that may be present in said sample of interest (i);
(c) illuminating said mixture formed in step (b) at a wavelength below 400 nanometers (nm); and
(d) measuring fluorescent emission from said illuminated mixture in step (c), said emission being proportional to the quantity of any nucleic acid present in said sample of interest (i).

### Claim 179 (depends on 178)

The process of claim 178, wherein said sample of interest (i) is suspected of containing a nucleic acid or nucleic acids of interest.

### Claim 180 (depends on 179)

The process of claim 179, wherein said nucleic acid or nucleic acids are double-stranded, single-stranded or a mixture of double-stranded and single-stranded nucleic acids

### Claim 181 (depends on 179)

The process of claim 179, wherein said nucleic acid or nucleic acids comprise DNA, RNA or a mixture of RNA and DNA.

### Claim 182 (depends on 178)

The process of claim 178, wherein said dye (ii) has the structure
33

### Claim 183 (depends on 179)

The process of claim 179, further comprising the step (b′) of hybridizing said nucleic acid or nucleic acids of interest to complementary nucleic acid strands or sequences fixed or immobilized to a solid support.

### Claim 184

The process of 183, wherein said solid support comprises beads, tubes, microtiter plates, glass slides, plastic slides, microchip arrays, well or depressions.

### Claim 185 (depends on 178)

The process of claim 178, wherein said illuminating step (c) is carried out at 350 nanometers (nm).

### Claim 186 (depends on 178)

The process of claim 178, wherein said measuring step (d) is carried out at greater than 550 nanometers (nm).

### Claim 187 (depends on 186)

The process of claim 186, wherein said measuring step (d) is carried out at 600 nanometers (nm).

### Claim 188 (depends on 178)

The process of claim 178, wherein said measuring step (d) is carried out after or during a primer binding step, a primer extension step, a denaturation step or a step that is added for the purpose of fluoresence measurement

### Claim 189 (depends on 178)

The process of claim 178, wherein said any of said process steps are carried out in a closed container.

### Claim 190 (depends on 189)

The process of claim 189, wherein said closed container system comprises an illumination source and a detection device or unit.

### Claim 191

A composition comprising at least one of the following dye structures:
34

### Claim 192 (depends on 191)

The composition of claim 191, wherein the phenyl ring has been substituted in the ortho, para or meta positions.

### Claim 193 (depends on 192)

The composition of claim 192, wherein said substitution is in the meta position of the phenyl ring.

### Claim 194 (depends on 191)

A process for determining the amount of a nucleic acid in a sample of interest, said process comprising the steps of:
(a) providing:
(i) said sample of interest;
(ii) the dye (a), (b), (c) or (d) from the composition of claim 191;
(iii) reagents for carrying out dye binding, hybridization, strand extension, or any combination thereof;
(b) forming a mixture of (i), (ii) and (iii) above, to produce a complex comprising said dye (ii) and any nucleic acid that may be present in said sample of interest (i);
(c) illuminating said mixture formed in step (b) at a first wavelength; and
(d) measuring at a second wavelength any fluorescent emission from said illuminated mixture in step (c), said emission being proportional to the quantity of any nucleic acid present in said sample of interest (i).

### Claim 195 (depends on 194)

The process of claim 194, wherein said sample of interest (i) is suspected of containing a nucleic acid or nucleic acids of interest.

### Claim 196 (depends on 195)

The process of claim 195, wherein said nucleic acid or nucleic acids are double-stranded, single-stranded or a mixture of double-stranded and single-stranded nucleic acids.

### Claim 197 (depends on 195)

The process of claim 195, wherein said nucleic acid or nucleic acids comprise DNA, RNA or a mixture of RNA and DNA.

### Claim 198 (depends on 195)

The process of claim 195, further comprising the step (b′) of hybridizing said nucleic acid or nucleic acids of interest to complementary nucleic acid strands or sequences fixed or immobilized to a solid support.

### Claim 199

The process of 198, wherein said solid support comprises beads, tubes, microtiter plates, glass slides, plastic slides, microchip arrays, well or depressions.

### Claim 200 (depends on 194)

The process of claim 194, wherein said measuring step (d) is carried out after or during a primer binding step, a primer extension step, a denaturation step or a step that is added for the purpose of fluoresence measurement.

### Claim 201 (depends on 194)

The process of claim 194, wherein said any of said process steps are carried out in a closed container.

### Claim 202 (depends on 201)

The process of claim 201, wherein said closed container system comprises an illumination source and a detection device or unit.

### Claim 203

A heterodimeric dye composition, said composition comprising a first dye that comprises a phenanthridinium moiety; and a second dye that is different from said first dye, said second dye being attached through the phenyl ring of said phenanthridium moiety.

### Claim 204 (depends on 203)

The heterodimeric dye composition of claim 203, having the structure
35
wherein said second dye is not a phenanthridinium moiety.

### Claim 205 (depends on 204)

The heterodimeric dye composition of claim 204, wherein said Second Dye is substituted in any of the ortho, meta or para positions of the phenyl ring.

### Claim 206 (depends on 205)

The heterodimeric dye composition of claim 205, wherein said Second Dye is substituted in the meta position of the phenyl ring.

### Claim 207 (depends on 203, 204)

The composition of claims 203 or 204, wherein said second dye comprises a thiazole, a fluorescein, a thiazole derivative, or a fluorescein derivative.

### Claim 208 (depends on 203)

A process for determining the amount of a nucleic acid in a sample of interest, said process comprising the steps of:
(a) providing:
(i) said sample of interest;
(ii) the dye of claim 203;
(iii) reagents for carrying out dye binding, hybridization, strand extension, or any combination thereof;
(b) forming a mixture of (i), (ii) and (iii) above, to produce a complex comprising said dye (ii) and any nucleic acid that may be present in said sample of interest (i);
(c) illuminating said mixture formed in step (b) at a first wavelength; and
(d) measuring at a second wavelength any fluorescent emission from said illuminated mixture in step (c), said emission being proportional to the quantity of any nucleic acid present in said sample of interest (i).

### Claim 209 (depends on 208)

The process of claim 208, wherein said sample of interest (i) is suspected of containing a nucleic acid or nucleic acids of interest.

### Claim 210 (depends on 209)

The process of claim 209, wherein said nucleic acid or nucleic acids are double-stranded, single-stranded or a mixture of double-stranded and single-stranded nucleic acids.

### Claim 211 (depends on 209)

The process of claim 209, wherein said nucleic acid or nucleic acids comprise DNA, RNA or a mixture of RNA and DNA.

### Claim 212 (depends on 208)

The process of claim 208, further comprising the step (b′) of hybridizing said nucleic acid or nucleic acids of interest to complementary nucleic acid strands or sequences fixed or immobilized to a solid support.

### Claim 213

The process of 212, wherein said solid support comprises beads, tubes, microtiter plates, glass slides, plastic slides, microchip arrays, well or depressions.

### Claim 214 (depends on 208)

The process of claim 208, wherein said measuring step (d) is carried out after or during a primer binding step, a primer extension step, a denaturation step or a step that is added for the purpose of fluoresence measurement.

### Claim 215 (depends on 208)

The process of claim 208, wherein said any of said process steps are carried out in a closed container.

### Claim 216 (depends on 215)

The process of claim 215, wherein said closed container system comprises an illumination source and a detection device or unit.

### Claim 217

A chemiluminescent reagent having the structure:
36
wherein Q comprises a cycloalkyl or polycycloalkyl group attached covalently to the 4-membered ring portion of said dioxetane above directly or indirectly through a linkage group; wherein Z comprises hydrogen, alkyl, aryl, aralkyl, alkaryl, heteroalkyl, heteroaryl, cycloalkyl or cycloheteroalkyl; and wherein R1 and R2 comprise chemical moieties attached to different sites of a cyclic ring attached to said dioxetane, and wherein R1 is enzymatically converted into R1* which comprises a chemical reactive group G1, and wherein R2 is attached to said cyclic ring through an oxygen atom and comprises a chemical reactive group G2 which reacts with said G1 to convert said dioxetane to an unstable light-emitting dioxetane form.

### Claim 218 (depends on 217)

The chemiluminescent reagent of claim 217, wherein said Q comprises an adamantyl group.

### Claim 219 (depends on 217)

The chemiluminescent reagent of claim 217, wherein said cyclic ring comprises an aromatic ring.

### Claim 220 (depends on 217)

The chemiluminescent reagent of claim 217, wherein R2 comprises a substituted or unsubstituted aliphatic group or an unsubstituted aromatic group.

### Claim 221 (depends on 220)

The chemiluminescent reagent of claim 220, wherein said substituted aliphatic group comprises halogen, nitrates, sulfonates or nitrites.

### Claim 222 (depends on 217)

The chemiluminescent reagent of claim 217, wherein enzymatically convertible R1 comprises amides, esters, phosphates, carboxylic acids, fatty acids, glucose, xylose, fucose, or amino acids.

### Claim 223 (depends on 217)

The chemiluminescent reagent of claim 217, wherein R1 is enzymatically converted into R1* through the action of enzymes comprising amidases, esterases, acetylcholinesterases, acid phosphatases, alkaline phosphatases, decarboxylases, lipases, glucosidases, xylosidases, fucosidases, trypsin or chymotrypsin.

### Claim 224 (depends on 217)

The chemiluminescent reagent of claim 217, wherein after said enzymatic conversion of R1 to R1* and before said conversion of said dioxetane to the unstable light-emitting dioxetane form, an intermediate five- or six-membered ring is formed comprising a linkage between said G1 and G2.

### Claim 225 (depends on 217)

A process for detecting the presence or quantity of enzymatic activity of interest in a sample, said process comprising the steps of:
(a) providing:
(i) said sample suspected of containing enzymatic activity;
(ii) the chemiluminescent reagent of claim 217;
(ii) reagents and buffers for carrying out chemiluminescent reactions;
(b) forming a mixture of:
(1) (i), (ii) and (iii); or
(2) (ii) and (iii) and contacting said mixture of (ii) and (iii) with (i);
(c) enzymatically converting the chemiluminescent reagent of claim 217 (ii) into an unstable light-emitting dioxetane form; and
(d) measuring the quantity of light generated by said enzymatic conversion in step (c).

### Claim 226 (depends on 225)

The process of claim 225, wherein in said providing step (a) Q in said chemiluminescent reagent (ii) comprises an adamantyl group.

### Claim 227 (depends on 225)

The process of claim 225, wherein in said providing step (a) R2 in said chemiluminescent reagent (ii) comprises a substituted or unsubstituted aliphatic group or an unsubstituted aromatic group.

### Claim 228 (depends on 227)

The process of claim 227, wherein said substituted aliphatic group comprises halogen, nitrates, sulfonates or nitrites.

### Claim 229 (depends on 225)

The process of claim 225, wherein said enzymatic converting step (c) is carried out by a substrate comprising amides, esters, phosphates, carboxylic acids, fatty acids, glucose, xylose, fucose, or amino acids.

### Claim 230 (depends on 225)

The process of claim 225, wherein said enzymatic activity of interest comprises an amidase, an esterase, an acetylcholinesterase, an acid phosphatase, an alkaline phosphatase, a decarboxylase, a lipase, a glucosidase, a xylosidase, a fucosidase, a trypsin or a chymotrypsin.

### Claim 231 (depends on 225)

The process of claim 225, further comprising the step of forming an intermediate five- or six-membered ring comprising a linkage between said G1 and G2 in said chemiluminescent reagent (ii).

### Claim 232 (depends on 225)

The process of claim 225, wherein any of said steps (a) through (d) are carried out in liquid phase or mixed phase.

### Claim 233 (depends on 225)

The process of claim 225, wherein said enzymatic activity of interest is dependent upon the presence or quantity of another compound.

### Claim 234 (depends on 233)

The process of claim 233, wherein said another compound comprises an RNA or DNA probe.

### Claim 235

A chemiluminescent reagent having the structure:
37
wherein Q comprises a cycloalkyl or polycycloalkyl group attached covalently to the 4-membered ring portion of said dioxetane above directly or indirectly through a linkage group; wherein Z comprises hydrogen, alkyl, aryl, aralkyl, alkaryl, heteroalkyl, heteroaryl, cycloalkyl or cycloheteroalkyl; and wherein R comprises a chemical linker having a reactive site attached to the aromatic ring in said structure; and wherein R′ comprises a substrate for an non-cleaving enzymatic process, wherein the product of said enzymatic process leads to further chemical rearrangements that generate an unstable light emitting dioxetane form.

### Claim 236 (depends on 235)

The chemiluminescent reagent of claim 235, wherein said non-cleaving enzymatic process comprises oxidation or reduction.

### Claim 237 (depends on 235)

The chemiluminescent reagent of claim 235, wherein said Q comprises an adamantyl group.

### Claim 238 (depends on 235)

The chemiluminescent reagent of claim 235, wherein R comprises a substituted or unsubstituted aliphatic group or an unsubstituted aromatic group.

### Claim 239 (depends on 238)

The chemiluminescent reagent of claim 238, wherein said substituted aliphatic group comprises halogen, nitrate, sulfonate or nitrite.

### Claim 240 (depends on 235)

The chemiluminescent reagent of claim 235, wherein said reactive site comprises an oxygen, a nitrogen or a sulfur atom.

### Claim 241 (depends on 235)

The chemiluminescent reagent of claim 235, wherein said enzymatic process is carried out by an enzyme comprising an oxidase or reductase.

### Claim 242 (depends on 235)

The chemiluminescent reagent of claim 235, wherein after said enzymatic process, said dioxetane is converted to an unstable light-emitting dioxetane form.

### Claim 243 (depends on 235, 344)

A process for detecting the presence or quantity of enzymatic activity of interest in a sample, said process comprising the steps of:
(a) providing:
(i) said sample suspected of containing enzymatic activity;
(ii) the chemiluminescent reagent of claim 235;
(ii) reagents and buffers for carrying out chemiluminescent reactions;
(b) forming a mixture of:
(1) (i), (ii) and (iii); or
(2) (ii) and (iii) and contacting said mixture of (ii) and (iii) with (i);
(c) enzymatically converting the chemiluminescent reagent of claim 344 (ii) into an unstable light-emitting dioxetane form; and
(d) measuring the quantity of light generated by said enzymatic conversion in step (c).

### Claim 244 (depends on 243)

The process of claim 243, wherein in said providing step (a) Q in said chemiluminescent reagent (ii) comprises an adamantyl group.

### Claim 245 (depends on 243)

The process of claim 243, wherein in said providing step (a) R in the chemiluminescent reagent (ii) comprises a substituted or unsubstituted aliphatic group or an unsubstituted aromatic group.

### Claim 246 (depends on 245)

The process of claim 245, wherein said substituted aliphatic group comprises halogen, nitrate, sulfonate or nitrite.

### Claim 247 (depends on 243)

The process of claim 243, wherein said providing step (a) R in the chemiluminescent reagent (ii) comprises a reactive site comprising an oxygen, a nitrogen or a sulfur atom.

### Claim 248 (depends on 243)

The process of claim 243, wherein said step of enzymatically converting (c) is carried out by an enzyme comprising an oxidase or reductase.

### Claim 249 (depends on 243)

The process of claim 243, wherein any of said steps (a) through (d) are carried out in liquid phase or mixed phase.

### Claim 250 (depends on 243)

The process of claim 243, wherein said enzymatic activity of interest is dependent upon the presence or quantity of another compound.

### Claim 251 (depends on 250)

The process of claim 250, wherein said another compound comprises an RNA or DNA probe.

### Claim 252

A dye composition of the formula
R-Fluorescent Dye
wherein R is covalently linked to said Fluorescent Dye comprises two or more members in combination from
a) unsaturated aliphatic groups;
b) unsaturated heterocyclic groups;
c) aromatic groups;
and wherein R is capable of providing a conjugated system or an electron delocalized system with said fluorescent dye.

### Claim 253 (depends on 252)

The dye composition of claim 252, wherein said unsaturated aliphatic groups comprise an alkene or an alkyne.

### Claim 254 (depends on 252)

The dye composition of claim 252, wherein said aromatic groups comprise a phenyl group, an aryl group or an aromatic heterocyclic group.

### Claim 255 (depends on 253, 254)

The dye composition of claims 253 or 254, wherein said unsaturated aliphatic groups or aromatic groups are substituted.

### Claim 256 (depends on 255)

The dye composition of claim 255, wherein said substituted unsaturated aliphatic groups or substituted aromatic groups comprise alkyl groups, aryl groups, alkoxy groups, phenoxy groups, amines, amino groups, amido groups, carboxy groups, nitrates, nitrites, sulfonates, sulfhydryl groups or phosphates.

### Claim 257 (depends on 255)

The dye composition of claim 255, wherein said substituted aromatic groups comprise a fused ring structure.

### Claim 258 (depends on 257)

The dye composition of claim 257, wherein said fused ring structure is a naphthalene, anthracene or a phenanthrene.

### Claim 259 (depends on 252)

The dye composition of claim 252, wherein said combination comprises two members of the same group or of different groups.

### Claim 260 (depends on 259)

The dye composition of claim 259, wherein said different groups comprise
an unsaturated aliphatic group (a) and an unsaturated heterocyclic group (b);
an unsaturated aliphatic group (a) and an aromatic group (c); or
an unsaturated heterocyclic group (b) and an aromatic group (c).

### Claim 261 (depends on 252)

The dye composition of claim 252, wherein said fluorescent dye comprises an anthracene, a xanthene, a cyanine, a porphyrin, a coumarin or a composite dye.

### Claim 262 (depends on 252)

The dye composition of claim 252, further comprising a charged or polar R′ group.

### Claim 263 (depends on 262)

The dye composition of claim 262, wherein said charged or polar R′ group increases aqueous solubility of said composition.

### Claim 264 (depends on 253, 262)

The dye composition of claim 253 or 262, further comprising a reactive group Rx attached to either said fluorescent dye, said R group or said R′ group.

### Claim 265 (depends on 264)

The dye composition of claim 264, further comprising a linker arm attaching said reactive group Rx to said fluorescent dye, said R group or said R′ group.

### Claim 266 (depends on 264)

The dye composition of claim 264, wherein said reactive group Rx comprises sulfhydryl, hydroxyl, amine, isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, maleimide, aziridine, sulfonylhalide, acid halide, hydroxysuccinimide ester, hydroxysulfosuccinimide ester, imidoester, hydrazine, azidonitrophenyl, azide, 3-(2-pyridyl dithio)-proprionamide, glyoxal or aldehyde.

### Claim 267 (depends on 265)

The dye composition of claim 265, wherein said reactive group Rx comprises sulfhydryl, hydroxyl, amine, isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, maleimide, aziridine, sulfonyihalide, acid halide, hydroxysuccinimide ester, hydroxysulfosuccinimide ester, imidoester, hydrazine, azidonitrophenyl, azide, 3-(2-pyridyl dithio)-proprionamide, glyoxal or aldehyde.

### Claim 268 (depends on 264)

The dye composition of claim 264, wherein as a reactive group R is capable of forming a carbon-carbon linkage with a target.

### Claim 269 (depends on 265)

The dye composition of claim 265, wherein as a reactive group R is capable of forming a carbon-carbon linkage with a target.

### Claim 270 (depends on 268)

The dye composition of claim 268, wherein said reactive group R comprises an alkene group, an alkyne group, a halogenated compound or a metallo-organic compound.

### Claim 271 (depends on 269)

The dye composition of claim 269, wherein said reactive group R comprises an alkene group, an alkyne group, a halogenated compound or a metallo-organic compound.

### Claim 272

A labeled target having the structure
{R-Dye[Brketclosest]target
wherein said Dye is a fluorescent dye, wherein R is covalently linked to said Dye, and wherein R comprises two or more members in combination from
a) unsaturated aliphatic groups;
b) unsaturated heterocyclic groups;
c) aromatic groups;
and wherein R is capable of providing a conjugated system or an electron delocalized system with said Dye.
comprises two or more unsaturated aliphatic groups, unsaturated heterocyclic groups, aromatic groups, or combinations of the foregoing groups and wherein R is covalently attached to said fluorescent dye and is capable of providing a conjugated system or an electron delocalized system with said fluorescent dye, and wherein said target is covalently attached to said Dye or said R.

### Claim 273 (depends on 272)

The labeled target of claim 272, wherein said unsaturated aliphatic groups comprise an alkene or an alkyne.

### Claim 274 (depends on 272)

The labeled target of claim 272, wherein said aromatic groups comprise a phenyl group, an aryl group or an aromatic heterocyclic group.

### Claim 275 (depends on 273, 274)

The labeled target of claims 273 or 274, wherein said unsaturated aliphatic groups or aromatic groups are substituted.

### Claim 276 (depends on 272)

The labeled target of claim 272, wherein said substituted unsaturated aliphatic groups or substituted aromatic groups comprise alkyl groups, aryl groups, alkoxy groups, phenoxy groups, amines, amino groups, amido groups, carboxy groups, nitrates, nitrites, sulfonates, sulfhydryl groups or phosphates.

### Claim 277 (depends on 275)

The labeled target of claim 275, wherein said substituted aromatic groups comprise a fused ring structure.

### Claim 278 (depends on 277)

The labeled target of claim 277, wherein said fused ring structure is a naphthalene, anthracene or a phenanthrene.

### Claim 279 (depends on 272)

The labeled target of claim 272, wherein said combination comprises two members of the same group or of different groups.

### Claim 280 (depends on 279)

The labeled target of claim 279, wherein said different groups comprise
an unsaturated aliphatic group (a) and an unsaturated heterocyclic group (b);
an unsaturated aliphatic group (a) and an aromatic group (c); or
an unsaturated heterocyclic group (b) and an aromatic group (c).

### Claim 281 (depends on 272)

The labeled target of claim 272, wherein said fluorescent dye comprises an anthracene, a xanthene, a cyanine, a porphyrin, a coumarin or a composite dye.

### Claim 282 (depends on 272)

The labeled target of claim 272, further comprising a charged or polar R′ group.

### Claim 283 (depends on 272)

The labeled target of claim 272, wherein said charged or polar R′ group increases aqueous solubility of said composition.

### Claim 284 (depends on 282)

The labeled target of claim 282, further comprising a linker arm attaching said target to said fluorescent dye, said R group or said R′ group.

### Claim 285 (depends on 272)

The labeled target of claim 272, wherein said target comprises a protein, a peptide, a nucleic acid, a nucleotide or a nucleotide analog, a receptor, a natural or synthetic drug, a synthetic oligomer, a synthetic polymer, a hormone, a lymphokine, a cytokine, a toxin, a ligand, an antigen, a hapten, an antibody, a carbohydrate, a sugar or an oligo- or polysaccharide.

### Claim 286 (depends on 285)

The labeled target of claim 285, wherein said ligand comprises biotin, iminobiotin, digoxygenin or fluorescein, and the dye comprises a fluorescent dye.
